Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Telo Genomics Corp (TELO.VN)

Telo Genomics Corp (TELO.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Telo Genomics Announces Its TeloViewSMM Test Is Accepted as Laboratory Developed Test by CAP Newsfile - Tue Jun 18, 7:50AM CDT

Toronto, Ontario--(Newsfile Corp. - June 18, 2024) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo") a biotech company developing the industry's leading telomere technology platform...

TDSGF : 0.1577 (+4.02%)
TELO.VN : 0.185 (-9.76%)
Telo Genomics Presents Proprietary Artificial Intelligence Methodologies at ASCO 2024 Newsfile - Wed Jun 12, 7:50AM CDT

Toronto, Ontario--(Newsfile Corp. - June 12, 2024) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (FSE: 3D0A) ("Telo" or the "Company"), is pleased to announce that results of the development, validation...

TDSGF : 0.1577 (+4.02%)
TELO.VN : 0.185 (-9.76%)
Telo Genomics Announces Publication of Results from Its Smoldering Myeloma Clinical Study in the American Journal of Hematology Newsfile - Thu May 30, 8:00AM CDT

Toronto, Ontario--(Newsfile Corp. - May 30, 2024) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (FSE: 3DOA), (the "Company" or "Telo"), a biotech company developing the industry's leading telomere...

TDSGF : 0.1577 (+4.02%)
TELO.VN : 0.185 (-9.76%)
Telo Genomics and Emery Pharma Announce Collaboration Newsfile - Wed May 15, 7:56AM CDT

Toronto, Ontario--(Newsfile Corp. - May 15, 2024) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo") a biotech company developing the industry's leading telomere technology platform...

TDSGF : 0.1577 (+4.02%)
TELO.VN : 0.185 (-9.76%)
Telo Genomics Receives Accreditation from College of American Pathologists Newsfile - Wed Apr 10, 7:52AM CDT

Toronto, Ontario--(Newsfile Corp. - April 10, 2024) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo") a biotech company developing the industry's leading telomere technology platform...

TDSGF : 0.1577 (+4.02%)
TELO.VN : 0.185 (-9.76%)
Telo Genomics' Flagship MRD Clinical Trial Expands into Multi-Center Trial Newsfile - Tue Apr 2, 7:52AM CDT

Toronto, Ontario--(Newsfile Corp. - April 2, 2024) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo") a biotech company developing the industry's leading telomere technology platform...

TDSGF : 0.1577 (+4.02%)
TELO.VN : 0.185 (-9.76%)
Telo Genomics Initiates MRD Clinical Trial for Multiple Myeloma Patients Newsfile - Tue Feb 13, 7:50AM CST

Toronto, Ontario--(Newsfile Corp. - February 13, 2024) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo") is pleased to announce that it has received the first patient sample for...

TDSGF : 0.1577 (+4.02%)
TELO.VN : 0.185 (-9.76%)
Multiple Myeloma Therapeutics Market Expected to Reach $4.26 Billion in 2030 FinancialNewsMedia - Tue Jan 30, 8:15AM CST

EQNX::TICKER_START (OTCQB:TDSGF),(TSXV:TELO),(NYSE:BMY),(NYSE:TMO),(NASDAQ:NTRA),(NASDAQ:NEO) EQNX::TICKER_END

TDSGF : 0.1577 (+4.02%)
TELO.VN : 0.185 (-9.76%)
BMY : 41.53 (+0.05%)
TMO : 553.00 (+0.40%)
NTRA : 108.29 (-1.56%)
NEO : 13.87 (+3.97%)
Multiple Myeloma Therapeutics Market Expected to Reach $4.26 Billion in 2030 GlobeNewswire - Tue Jan 30, 8:15AM CST

TDSGF : 0.1577 (+4.02%)
TELO.VN : 0.185 (-9.76%)
BMY : 41.53 (+0.05%)
TMO : 553.00 (+0.40%)
NTRA : 108.29 (-1.56%)
NEO : 13.87 (+3.97%)
Telo Genomics Engages US Diagnostics Experts to Power Product Adoption in the US Newsfile - Tue Jan 30, 7:56AM CST

Toronto, Ontario--(Newsfile Corp. - January 30, 2024) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo") is pleased to announce that it has engaged Trusted Health Advisors (THA),...

TDSGF : 0.1577 (+4.02%)
TELO.VN : 0.185 (-9.76%)

Barchart Exclusives

Chart of the Day: ACI Worldwide - Improved Profit and Buy-Backs Barchart - 12 minutes ago
The Chart of the Day belongs to the software company ACI Worldwide (ACIW) . I found the stock by using Barchart's powerful screening functions to find stocks with the highest technical buy signals, highest Weighted Alpha, superior current momentum and having a Trend Seeker buy signal then used the Flipchart... Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot